Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-1636.78%
operating margin TTM
-3205.76%
revenue TTM
232.47 Thousand
revenue per share TTM
0.03$
valuation ratios | |
|---|---|
| pe ratio | -2.41 |
| peg ratio | 0.13 |
| price to book ratio | 1.49 |
| price to sales ratio | 36.40 |
| enterprise value multiple | -1.27 |
| price fair value | 1.49 |
profitability ratios | |
|---|---|
| gross profit margin | 70.78% |
| operating profit margin | -3205.76% |
| pretax profit margin | -1636.78% |
| net profit margin | -1636.78% |
| return on assets | -42.34% |
| return on equity | -54.49% |
| return on capital employed | -120.96% |
liquidity ratio | |
|---|---|
| current ratio | 2.95 |
| quick ratio | 2.95 |
| cash ratio | 0.33 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 159.75 |
| days of payables outstanding | 1,329.93 |
| cash conversion cycle | -1,170.18 |
| receivables turnover | 2.28 |
| payables turnover | 0.27 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.00 |
| debt equity ratio | 0.00 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.00 |
| interest coverage | -68.64 |
| cash flow to debt ratio | -180.50 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.96 |
| cash per share | 1.61 |
| operating cash flow per share | -0.94 |
| free cash flow operating cash flow ratio | 1.02 |
| cash flow coverage ratios | -180.50 |
| short term coverage ratios | -180.50 |
| capital expenditure coverage ratio | -46.75 |
Frequently Asked Questions
When was the last time BioRestorative Therapies, Inc. (NASDAQ:BRTX) reported earnings?
BioRestorative Therapies, Inc. (BRTX) published its most recent earnings results on 12-11-2024.
What is BioRestorative Therapies, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. BioRestorative Therapies, Inc. (NASDAQ:BRTX)'s trailing twelve months ROE is -54.49%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. BioRestorative Therapies, Inc. (BRTX) currently has a ROA of -42.34%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did BRTX's net profit margin stand at?
BRTX reported a profit margin of -1636.78% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is BRTX's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.95 in the most recent quarter. The quick ratio stood at 2.95, with a Debt/Eq ratio of 0.00.